These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Safety and Efficacy of Switching From Clopidogrel to Prasugrel in Patients Undergoing Percutaneous Coronary Intervention: A Study-level Meta-analysis From 15 Studies. Patti G; Ricottini E; De Luca L; Cavallari I J Cardiovasc Pharmacol; 2016 Apr; 67(4):336-43. PubMed ID: 26771153 [TBL] [Abstract][Full Text] [Related]
9. Efficacy of ex vivo autologous and in vivo platelet transfusion in the reversal of P2Y12 inhibition by clopidogrel, prasugrel, and ticagrelor: the APTITUDE study. O'Connor SA; Amour J; Mercadier A; Martin R; Kerneis M; Abtan J; Brugier D; Silvain J; Barthélémy O; Leprince P; Montalescot G; Collet JP; Circ Cardiovasc Interv; 2015 Nov; 8(11):e002786. PubMed ID: 26553698 [TBL] [Abstract][Full Text] [Related]
10. Comparing prasugrel to twice daily clopidogrel post percutaneous coronary intervention in a Veterans Affairs population. Khatri S; Pierce T Am J Health Syst Pharm; 2015 Sep; 72(17 Suppl 2):S98-S103. PubMed ID: 26272900 [TBL] [Abstract][Full Text] [Related]
11. Switching From Ticagrelor or Prasugrel to Clopidogrel. Nawarskas JJ; Montoya TN Cardiol Rev; 2018; 26(2):107-111. PubMed ID: 29215418 [TBL] [Abstract][Full Text] [Related]
12. The role of prasugrel in the management of acute coronary syndromes: a systematic review. Spartalis M; Tzatzaki E; Spartalis E; Damaskos C; Athanasiou A; Moris D; Politou M Eur Rev Med Pharmacol Sci; 2017 Oct; 21(20):4733-4743. PubMed ID: 29131238 [TBL] [Abstract][Full Text] [Related]
13. Switching from Clopidogrel to Prasugrel in patients undergoing PCI: A meta-analytic overview. Verdoia M; Barbieri L; Suryapranata H; De Luca G Platelets; 2016; 27(2):93-104. PubMed ID: 25970631 [TBL] [Abstract][Full Text] [Related]
14. MULTInational non-interventional study of patients with ST-segment elevation myocardial infarction treated with PRimary Angioplasty and Concomitant use of upstream antiplatelet therapy with prasugrel or clopidogrel--the European MULTIPRAC Registry. Clemmensen P; Grieco N; Ince H; Danchin N; Goedicke J; Ramos Y; Schmitt J; Goldstein P; Eur Heart J Acute Cardiovasc Care; 2015 Jun; 4(3):220-9. PubMed ID: 25182465 [TBL] [Abstract][Full Text] [Related]
15. Randomized Comparison of Oral P2Y Hochholzer W; Kleiner P; Younas I; Valina CM; Löffelhardt N; Amann M; Bömicke T; Ferenc M; Hauschke D; Trenk D; Neumann FJ; Stratz C JACC Cardiovasc Interv; 2017 Jan; 10(2):121-129. PubMed ID: 28104204 [TBL] [Abstract][Full Text] [Related]
16. Comparative Effectiveness and Safety Analysis of Dual Antiplatelet Therapies Within an Integrated Delivery System. Coons JC; Iasella CJ; Chanas T; Wang N; Williams K; Boyd A; Lyons J; Eckardt J; Rihtarchik L; Merkel A; Chambers A; Lemon LS; Smith R; Ensor CR Ann Pharmacother; 2017 Aug; 51(8):649-655. PubMed ID: 28438043 [TBL] [Abstract][Full Text] [Related]
17. Comparative Efficacy and Safety of Prasugrel, Ticagrelor, and Standard-Dose and High-Dose Clopidogrel in Patients Undergoing Percutaneous Coronary Intervention: A Network Meta-analysis. Singh S; Singh M; Grewal N; Khosla S Am J Ther; 2016; 23(1):e52-62. PubMed ID: 26448337 [TBL] [Abstract][Full Text] [Related]
18. A randomised trial on platelet function-guided de-escalation of antiplatelet treatment in ACS patients undergoing PCI. Rationale and design of the Testing Responsiveness to Platelet Inhibition on Chronic Antiplatelet Treatment for Acute Coronary Syndromes (TROPICAL-ACS) Trial. Sibbing D; Aradi D; Jacobshagen C; Gross L; Trenk D; Geisler T; Orban M; Gori T; Hadamitzky M; Merkely B; Kiss RG; Komócsi A; Dézsi CA; Thalmeier A; Löw A; Holdt L; Teupser D; Ince H; Felix SB; Parma R; Malek L; Horstkotte J; Baylacher M; Schwinger R; Rieber J; Mudra H; Hausleiter J; Huber K; Neumann FJ; Koltowski L; Huczek Z; Mehilli J; Massberg S; Thromb Haemost; 2017 Jan; 117(1):188-195. PubMed ID: 27652610 [TBL] [Abstract][Full Text] [Related]
19. Outcomes of Patients With Acute Myocardial Infarction Undergoing Percutaneous Coronary Intervention Receiving an Oral Anticoagulant and Dual Antiplatelet Therapy: A Comparison of Clopidogrel Versus Prasugrel From the TRANSLATE-ACS Study. Jackson LR; Ju C; Zettler M; Messenger JC; Cohen DJ; Stone GW; Baker BA; Effron M; Peterson ED; Wang TY JACC Cardiovasc Interv; 2015 Dec; 8(14):1880-9. PubMed ID: 26718518 [TBL] [Abstract][Full Text] [Related]
20. A comparative evaluation of prasugrel and clopidogrel in patients with acute coronary syndrome undergoing percutaneous coronary intervention. Dasbiswas A; Rao MS; Babu PR; Vijayvergiya R; Nayak R; Dani S; Tyagi S; Hiremath S; Patel T; Alexander T; Prakash VS; Singh DP; Yadav MK; Pathak K; Srivastava A J Assoc Physicians India; 2013 Feb; 61(2):114-6, 126. PubMed ID: 24471250 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]